PROVIDER PROFILE · NPI 1568575140
Andrew KopelMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,064
Unique beneficiaries
—
Total services
25,502
Distinct HCPCS
18
Medicare payment
$1.2M
Peer benchmark
Total Medicare services vs. 1,238 Ophthalmology providers in TX — top quintile (cohort median 1,864).
PRESCRIBING · PART D · 2024
Total Rx claims
858
Beneficiaries
—
Total drug cost
$58K
Distinct drugs
14
Brand share
39.0%
Top prescribed drugs
Latanoprost184 claims
Timolol Maleate158 claims
Erythromycin Base109 claims
Moxifloxacin Hcl81 claims
Prednisolone Acetate79 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$586
Payment records
19
By payment type
Food and Beverage$586
Top paying entities
Food and Beverage$586
REFERRAL NETWORK
Where Andrew Kopel's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX | 20 | 47 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE